Increasing use of smoking cessation services with risk information and taster sessions

Completed

• Conditions: Smoking cessation; Mental and Behavioural Disorders; Mental and behavioural disorders due to use of tobacco

• Registration Number: ISRCTN76561916
• Lead Sponsor: niversity College London (UCL) (UK)

Brief Summary

1. 2012 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/23078797 2. 2016 results in https://www.ncbi.nlm.nih.gov/pubmed/28031035 3. 2017 results in: http://www.ncbi.nlm.nih.gov/pubmed/28121288 4. 2017 results in: http://www.ncbi.nlm.nih.gov/pubmed/28129989

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-12-10
• Study Completion: 2014-03-31
• Last Update Posted: 19 March 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2520

Inclusion Criteria

All current smokers:
1. Willing to participate and returning the signed consent form
2. Aged 16 years and over, either sex
3. Able to read English
4. Motivated to quit
5. Have not previously attended the NHS services

Exclusion Criteria

Exclusion criteria are minimal because the aim is to recruit all smokers into the services. However, smokers younger than 16 will be excluded because of the need for parental consent to participate for this age group, and any patients identified who are considered by the GP to be unsuitable for the project, e.g. severely or terminally ill, will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of people entering the smoking cessation service (i.e. attending the first session of a 6-week course) over a period of 6 months from the receipt of the invitation letter. Self-reported attendance data will be validated by records of attendance at the NHS services.

Secondary Outcome Measures

Name	Time	Method
1. 7-day point prevalent abstinence at the 6-month follow-up, validated by salivary cotinine for all participants reporting abstinence in both the intervention and control groups<br>2. Prolonged periods of abstinence of 7 days to 24 weeks measured by self-report<br>3. Self-reported changes in daily cigarette consumption, quit attempts, and changes in motivation and intention to quit in continuing smokers<br>4. Use of NRT or Zyban or Champix and other smoking cessation aids<br>5. The number completing the 6-week NHS course<br>6. Process measures: <br>6.1. The number of smokers attending the taster session (intervention group only) <br>6.2. Perception of the personal invitation letters<br>6.3. Reasons for non-attendance at the taster session and barriers to attendance at the NHS services